nodes	percent_of_prediction	percent_of_DWPC	metapath
Foscarnet—SLC16A1—Methotrexate—breast cancer	0.244	0.827	CbGbCtD
Foscarnet—SLC22A6—Methotrexate—breast cancer	0.0511	0.173	CbGbCtD
Foscarnet—SLC22A6—Organic cation/anion/zwitterion transport—SLC22A18—breast cancer	0.00517	0.0698	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism—LDHB—breast cancer	0.00362	0.0489	CbGpPWpGaD
Foscarnet—SLC16A1—Pyruvate metabolism and Citric Acid (TCA) cycle—LDHB—breast cancer	0.00219	0.0296	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.0021	0.0284	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00174	0.0235	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00159	0.0215	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.00154	0.0207	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—NDUFS3—breast cancer	0.0014	0.0189	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A10—breast cancer	0.00137	0.0184	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.00132	0.0178	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—COX11—breast cancer	0.00125	0.0169	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—MMP1—breast cancer	0.00119	0.016	CbGpPWpGaD
Foscarnet—SLC16A1—Basigin interactions—CAV1—breast cancer	0.00114	0.0154	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A7—breast cancer	0.00113	0.0153	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.00105	0.0141	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A18—breast cancer	0.00104	0.014	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A5—breast cancer	0.000996	0.0135	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000956	0.0129	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000956	0.0129	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—GRB7—breast cancer	0.00086	0.0116	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC39A6—breast cancer	0.000858	0.0116	CbGpPWpGaD
Foscarnet—SLC16A1—The citric acid (TCA) cycle and respiratory electron transport—LDHB—breast cancer	0.00085	0.0115	CbGpPWpGaD
Foscarnet—SLC16A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000795	0.0107	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000792	0.0107	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.000725	0.00978	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000698	0.00942	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000698	0.00942	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GUCY1A2—breast cancer	0.000689	0.0093	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC28A1—breast cancer	0.000679	0.00916	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC4A7—breast cancer	0.000621	0.00838	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A10—breast cancer	0.000621	0.00838	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.0006	0.00811	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HRG—breast cancer	0.000561	0.00758	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000531	0.00717	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—C1QBP—breast cancer	0.000522	0.00705	CbGpPWpGaD
Foscarnet—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—breast cancer	0.000516	0.00697	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC39A7—breast cancer	0.000514	0.00694	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000486	0.00656	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000486	0.00656	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC22A18—breast cancer	0.00047	0.00635	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLCO1B1—breast cancer	0.000453	0.00611	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A5—breast cancer	0.000453	0.00611	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAD51B—breast cancer	0.000425	0.00574	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—COX11—breast cancer	0.000403	0.00544	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000403	0.00544	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—MMP1—breast cancer	0.000395	0.00533	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC39A6—breast cancer	0.00039	0.00526	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—CAV1—breast cancer	0.000378	0.00511	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000368	0.00497	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAD51C—breast cancer	0.000362	0.00488	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—SERPINB2—breast cancer	0.000362	0.00488	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000361	0.00488	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—FN1—breast cancer	0.00036	0.00486	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.000354	0.00479	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.000354	0.00479	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PDE2A—breast cancer	0.000353	0.00476	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC28A1—breast cancer	0.000345	0.00466	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KDM1A—breast cancer	0.000336	0.00454	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—STIM1—breast cancer	0.000322	0.00435	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC4A7—breast cancer	0.000315	0.00426	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A10—breast cancer	0.000315	0.00426	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000305	0.00412	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.00029	0.00391	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—F3—breast cancer	0.000282	0.0038	CbGpPWpGaD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.00028	0.00378	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000279	0.00377	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CB—breast cancer	0.000264	0.00357	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC39A7—breast cancer	0.000261	0.00353	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—COX11—breast cancer	0.000261	0.00353	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000259	0.0035	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC22A18—breast cancer	0.000239	0.00323	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CFL1—breast cancer	0.000235	0.00318	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—breast cancer	0.000234	0.00317	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GRB7—breast cancer	0.000233	0.00315	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLCO1B1—breast cancer	0.00023	0.00311	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A5—breast cancer	0.00023	0.00311	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SYNJ2—breast cancer	0.000228	0.00307	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000221	0.00298	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALDOA—breast cancer	0.00022	0.00297	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—VEGFC—breast cancer	0.00022	0.00297	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—SRC—breast cancer	0.000212	0.00286	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NDUFS3—breast cancer	0.000212	0.00286	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CHST9—breast cancer	0.000199	0.00269	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC39A6—breast cancer	0.000198	0.00267	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—COX11—breast cancer	0.000189	0.00255	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—breast cancer	0.000188	0.00254	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TGFB2—breast cancer	0.000185	0.0025	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—THBS1—breast cancer	0.000184	0.00249	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000184	0.00248	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—GATA3—breast cancer	0.000182	0.00245	CbGpPWpGaD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—breast cancer	0.000182	0.00245	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ATP7B—breast cancer	0.000181	0.00245	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCG2—breast cancer	0.00018	0.00243	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—KRAS—breast cancer	0.000175	0.00237	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SHMT1—breast cancer	0.000172	0.00233	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CDA—breast cancer	0.000172	0.00233	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCC1—breast cancer	0.000168	0.00227	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLCO1B1—breast cancer	0.000166	0.00224	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SLC2A5—breast cancer	0.000166	0.00224	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IFNB1—breast cancer	0.000163	0.0022	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—PIK3CA—breast cancer	0.000161	0.00217	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—APRT—breast cancer	0.00016	0.00216	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—TFRC—breast cancer	0.00016	0.00216	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—NCOA2—breast cancer	0.000154	0.00208	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ANGPTL4—breast cancer	0.000151	0.00204	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ESRRA—breast cancer	0.000151	0.00204	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PLAUR—breast cancer	0.00015	0.00202	CbGpPWpGaD
Foscarnet—SLC16A1—Cell surface interactions at the vascular wall—HRAS—breast cancer	0.000149	0.00201	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC5A5—breast cancer	0.000147	0.00199	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PLG—breast cancer	0.000146	0.00198	CbGpPWpGaD
Foscarnet—Infection—Capecitabine—breast cancer	0.000145	0.000231	CcSEcCtD
Foscarnet—Erythema multiforme—Methotrexate—breast cancer	0.000145	0.00023	CcSEcCtD
Foscarnet—Neuropathy peripheral—Doxorubicin—breast cancer	0.000145	0.00023	CcSEcCtD
Foscarnet—Dizziness—Irinotecan—breast cancer	0.000145	0.000229	CcSEcCtD
Foscarnet—Anorexia—Docetaxel—breast cancer	0.000144	0.000229	CcSEcCtD
Foscarnet—Rhinitis—Epirubicin—breast cancer	0.000144	0.000228	CcSEcCtD
Foscarnet—Urinary tract infection—Doxorubicin—breast cancer	0.000144	0.000228	CcSEcCtD
Foscarnet—Conjunctivitis—Doxorubicin—breast cancer	0.000144	0.000228	CcSEcCtD
Foscarnet—Eye disorder—Methotrexate—breast cancer	0.000143	0.000227	CcSEcCtD
Foscarnet—Diarrhoea—Fluorouracil—breast cancer	0.000143	0.000227	CcSEcCtD
Foscarnet—Thrombocytopenia—Capecitabine—breast cancer	0.000143	0.000227	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—TUBB3—breast cancer	0.000143	0.00193	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HADHB—breast cancer	0.000143	0.00193	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPI—breast cancer	0.000143	0.00193	CbGpPWpGaD
Foscarnet—Hypoaesthesia—Epirubicin—breast cancer	0.000143	0.000227	CcSEcCtD
Foscarnet—Pharyngitis—Epirubicin—breast cancer	0.000142	0.000226	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—SLC2A1—breast cancer	0.000142	0.00192	CbGpPWpGaD
Foscarnet—Hyperhidrosis—Capecitabine—breast cancer	0.000141	0.000224	CcSEcCtD
Foscarnet—Hypotension—Docetaxel—breast cancer	0.000141	0.000224	CcSEcCtD
Foscarnet—Haematuria—Doxorubicin—breast cancer	0.000141	0.000224	CcSEcCtD
Foscarnet—Body temperature increased—Paclitaxel—breast cancer	0.000141	0.000224	CcSEcCtD
Foscarnet—Abdominal pain—Paclitaxel—breast cancer	0.000141	0.000224	CcSEcCtD
Foscarnet—Urethral disorder—Epirubicin—breast cancer	0.000141	0.000223	CcSEcCtD
Foscarnet—Anorexia—Capecitabine—breast cancer	0.00014	0.000221	CcSEcCtD
Foscarnet—Vomiting—Irinotecan—breast cancer	0.000139	0.000221	CcSEcCtD
Foscarnet—Vomiting—Mitoxantrone—breast cancer	0.000139	0.000221	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PDGFA—breast cancer	0.000139	0.00188	CbGpPWpGaD
Foscarnet—Sinusitis—Doxorubicin—breast cancer	0.000139	0.00022	CcSEcCtD
Foscarnet—Dizziness—Fluorouracil—breast cancer	0.000138	0.00022	CcSEcCtD
Foscarnet—SLC16A1—SLC-mediated transmembrane transport—ALB—breast cancer	0.000138	0.00187	CbGpPWpGaD
Foscarnet—Agranulocytosis—Doxorubicin—breast cancer	0.000138	0.000219	CcSEcCtD
Foscarnet—Rash—Mitoxantrone—breast cancer	0.000138	0.000219	CcSEcCtD
Foscarnet—Rash—Irinotecan—breast cancer	0.000138	0.000219	CcSEcCtD
Foscarnet—Dermatitis—Mitoxantrone—breast cancer	0.000138	0.000219	CcSEcCtD
Foscarnet—Dermatitis—Irinotecan—breast cancer	0.000138	0.000219	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Docetaxel—breast cancer	0.000138	0.000218	CcSEcCtD
Foscarnet—Chills—Methotrexate—breast cancer	0.000138	0.000218	CcSEcCtD
Foscarnet—Headache—Mitoxantrone—breast cancer	0.000137	0.000217	CcSEcCtD
Foscarnet—Headache—Irinotecan—breast cancer	0.000137	0.000217	CcSEcCtD
Foscarnet—Hypotension—Capecitabine—breast cancer	0.000137	0.000217	CcSEcCtD
Foscarnet—Insomnia—Docetaxel—breast cancer	0.000137	0.000217	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—ALDH7A1—breast cancer	0.000136	0.00184	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDH1A1—breast cancer	0.000136	0.00184	CbGpPWpGaD
Foscarnet—Paraesthesia—Docetaxel—breast cancer	0.000136	0.000215	CcSEcCtD
Foscarnet—Erythema multiforme—Epirubicin—breast cancer	0.000136	0.000215	CcSEcCtD
Foscarnet—Vomiting—Gemcitabine—breast cancer	0.000135	0.000215	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ITPR1—breast cancer	0.000135	0.00182	CbGpPWpGaD
Foscarnet—Dyspnoea—Docetaxel—breast cancer	0.000135	0.000214	CcSEcCtD
Foscarnet—Somnolence—Docetaxel—breast cancer	0.000134	0.000213	CcSEcCtD
Foscarnet—Rash—Gemcitabine—breast cancer	0.000134	0.000213	CcSEcCtD
Foscarnet—Dermatitis—Gemcitabine—breast cancer	0.000134	0.000213	CcSEcCtD
Foscarnet—Eye disorder—Epirubicin—breast cancer	0.000134	0.000213	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—ABL1—breast cancer	0.000134	0.00181	CbGpPWpGaD
Foscarnet—Headache—Gemcitabine—breast cancer	0.000133	0.000212	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Capecitabine—breast cancer	0.000133	0.000212	CcSEcCtD
Foscarnet—Flushing—Epirubicin—breast cancer	0.000133	0.000211	CcSEcCtD
Foscarnet—Vomiting—Fluorouracil—breast cancer	0.000133	0.000211	CcSEcCtD
Foscarnet—Rhinitis—Doxorubicin—breast cancer	0.000133	0.000211	CcSEcCtD
Foscarnet—Dyspepsia—Docetaxel—breast cancer	0.000133	0.000211	CcSEcCtD
Foscarnet—Insomnia—Capecitabine—breast cancer	0.000132	0.00021	CcSEcCtD
Foscarnet—Hypoaesthesia—Doxorubicin—breast cancer	0.000132	0.00021	CcSEcCtD
Foscarnet—Rash—Fluorouracil—breast cancer	0.000132	0.000209	CcSEcCtD
Foscarnet—Dermatitis—Fluorouracil—breast cancer	0.000132	0.000209	CcSEcCtD
Foscarnet—Pharyngitis—Doxorubicin—breast cancer	0.000132	0.000209	CcSEcCtD
Foscarnet—Paraesthesia—Capecitabine—breast cancer	0.000131	0.000208	CcSEcCtD
Foscarnet—Decreased appetite—Docetaxel—breast cancer	0.000131	0.000208	CcSEcCtD
Foscarnet—Headache—Fluorouracil—breast cancer	0.000131	0.000208	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—UMPS—breast cancer	0.000131	0.00176	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PHGDH—breast cancer	0.000131	0.00176	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NME1—breast cancer	0.000131	0.00176	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—FHL2—breast cancer	0.000131	0.00176	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ADSL—breast cancer	0.000131	0.00176	CbGpPWpGaD
Foscarnet—Dyspnoea—Capecitabine—breast cancer	0.00013	0.000207	CcSEcCtD
Foscarnet—Fatigue—Docetaxel—breast cancer	0.00013	0.000207	CcSEcCtD
Foscarnet—Urethral disorder—Doxorubicin—breast cancer	0.00013	0.000206	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—NCOA1—breast cancer	0.00013	0.00176	CbGpPWpGaD
Foscarnet—Nausea—Irinotecan—breast cancer	0.00013	0.000206	CcSEcCtD
Foscarnet—Nausea—Mitoxantrone—breast cancer	0.00013	0.000206	CcSEcCtD
Foscarnet—Constipation—Docetaxel—breast cancer	0.000129	0.000205	CcSEcCtD
Foscarnet—Pain—Docetaxel—breast cancer	0.000129	0.000205	CcSEcCtD
Foscarnet—Back pain—Methotrexate—breast cancer	0.000129	0.000205	CcSEcCtD
Foscarnet—Dyspepsia—Capecitabine—breast cancer	0.000129	0.000204	CcSEcCtD
Foscarnet—Chills—Epirubicin—breast cancer	0.000129	0.000204	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—HPSE—breast cancer	0.000128	0.00173	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—BRIP1—breast cancer	0.000128	0.00173	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—LDHB—breast cancer	0.000128	0.00173	CbGpPWpGaD
Foscarnet—Asthenia—Paclitaxel—breast cancer	0.000128	0.000203	CcSEcCtD
Foscarnet—Decreased appetite—Capecitabine—breast cancer	0.000127	0.000202	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—PLG—breast cancer	0.000127	0.00171	CbGpPWpGaD
Foscarnet—Nausea—Gemcitabine—breast cancer	0.000127	0.000201	CcSEcCtD
Foscarnet—Fatigue—Capecitabine—breast cancer	0.000126	0.0002	CcSEcCtD
Foscarnet—Pruritus—Paclitaxel—breast cancer	0.000126	0.0002	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PLA2G4A—breast cancer	0.000126	0.0017	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HGF—breast cancer	0.000126	0.0017	CbGpPWpGaD
Foscarnet—Erythema multiforme—Doxorubicin—breast cancer	0.000126	0.000199	CcSEcCtD
Foscarnet—Constipation—Capecitabine—breast cancer	0.000125	0.000199	CcSEcCtD
Foscarnet—Pain—Capecitabine—breast cancer	0.000125	0.000199	CcSEcCtD
Foscarnet—Feeling abnormal—Docetaxel—breast cancer	0.000125	0.000198	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—CSF2—breast cancer	0.000124	0.00168	CbGpPWpGaD
Foscarnet—Nausea—Fluorouracil—breast cancer	0.000124	0.000197	CcSEcCtD
Foscarnet—Eye disorder—Doxorubicin—breast cancer	0.000124	0.000197	CcSEcCtD
Foscarnet—Ill-defined disorder—Methotrexate—breast cancer	0.000124	0.000196	CcSEcCtD
Foscarnet—Gastrointestinal pain—Docetaxel—breast cancer	0.000124	0.000196	CcSEcCtD
Foscarnet—Anaemia—Methotrexate—breast cancer	0.000123	0.000196	CcSEcCtD
Foscarnet—Flushing—Doxorubicin—breast cancer	0.000123	0.000195	CcSEcCtD
Foscarnet—Flatulence—Epirubicin—breast cancer	0.000123	0.000195	CcSEcCtD
Foscarnet—Tension—Epirubicin—breast cancer	0.000123	0.000194	CcSEcCtD
Foscarnet—Diarrhoea—Paclitaxel—breast cancer	0.000122	0.000194	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—HMMR—breast cancer	0.000122	0.00164	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCC1—breast cancer	0.000122	0.00164	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA3—breast cancer	0.000122	0.00164	CbGpPWpGaD
Foscarnet—Nervousness—Epirubicin—breast cancer	0.000121	0.000192	CcSEcCtD
Foscarnet—Back pain—Epirubicin—breast cancer	0.000121	0.000192	CcSEcCtD
Foscarnet—Feeling abnormal—Capecitabine—breast cancer	0.000121	0.000191	CcSEcCtD
Foscarnet—Malaise—Methotrexate—breast cancer	0.00012	0.000191	CcSEcCtD
Foscarnet—Muscle spasms—Epirubicin—breast cancer	0.00012	0.000191	CcSEcCtD
Foscarnet—Gastrointestinal pain—Capecitabine—breast cancer	0.00012	0.00019	CcSEcCtD
Foscarnet—Abdominal pain—Docetaxel—breast cancer	0.000119	0.00019	CcSEcCtD
Foscarnet—Body temperature increased—Docetaxel—breast cancer	0.000119	0.00019	CcSEcCtD
Foscarnet—Leukopenia—Methotrexate—breast cancer	0.000119	0.00019	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A2—breast cancer	0.000119	0.00161	CbGpPWpGaD
Foscarnet—Chills—Doxorubicin—breast cancer	0.000119	0.000189	CcSEcCtD
Foscarnet—Dizziness—Paclitaxel—breast cancer	0.000118	0.000187	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—PPARGC1B—breast cancer	0.000118	0.00159	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—HMOX1—breast cancer	0.000117	0.00158	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCG2—breast cancer	0.000117	0.00158	CbGpPWpGaD
Foscarnet—Cough—Methotrexate—breast cancer	0.000116	0.000185	CcSEcCtD
Foscarnet—Ill-defined disorder—Epirubicin—breast cancer	0.000116	0.000184	CcSEcCtD
Foscarnet—Abdominal pain—Capecitabine—breast cancer	0.000116	0.000184	CcSEcCtD
Foscarnet—Body temperature increased—Capecitabine—breast cancer	0.000116	0.000184	CcSEcCtD
Foscarnet—Convulsion—Methotrexate—breast cancer	0.000116	0.000183	CcSEcCtD
Foscarnet—Anaemia—Epirubicin—breast cancer	0.000115	0.000183	CcSEcCtD
Foscarnet—Agitation—Epirubicin—breast cancer	0.000115	0.000182	CcSEcCtD
Foscarnet—Flatulence—Doxorubicin—breast cancer	0.000114	0.000181	CcSEcCtD
Foscarnet—Chest pain—Methotrexate—breast cancer	0.000114	0.00018	CcSEcCtD
Foscarnet—Arthralgia—Methotrexate—breast cancer	0.000114	0.00018	CcSEcCtD
Foscarnet—Myalgia—Methotrexate—breast cancer	0.000114	0.00018	CcSEcCtD
Foscarnet—Tension—Doxorubicin—breast cancer	0.000113	0.00018	CcSEcCtD
Foscarnet—Vomiting—Paclitaxel—breast cancer	0.000113	0.00018	CcSEcCtD
Foscarnet—Malaise—Epirubicin—breast cancer	0.000113	0.000179	CcSEcCtD
Foscarnet—Rash—Paclitaxel—breast cancer	0.000112	0.000178	CcSEcCtD
Foscarnet—Dermatitis—Paclitaxel—breast cancer	0.000112	0.000178	CcSEcCtD
Foscarnet—Discomfort—Methotrexate—breast cancer	0.000112	0.000178	CcSEcCtD
Foscarnet—Nervousness—Doxorubicin—breast cancer	0.000112	0.000178	CcSEcCtD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ABCB1—breast cancer	0.000112	0.00152	CbGpPWpGaD
Foscarnet—Leukopenia—Epirubicin—breast cancer	0.000112	0.000177	CcSEcCtD
Foscarnet—Back pain—Doxorubicin—breast cancer	0.000112	0.000177	CcSEcCtD
Foscarnet—Headache—Paclitaxel—breast cancer	0.000112	0.000177	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GSTA4—breast cancer	0.000111	0.0015	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CA9—breast cancer	0.000111	0.0015	CbGpPWpGaD
Foscarnet—Muscle spasms—Doxorubicin—breast cancer	0.000111	0.000176	CcSEcCtD
Foscarnet—Palpitations—Epirubicin—breast cancer	0.00011	0.000175	CcSEcCtD
Foscarnet—Confusional state—Methotrexate—breast cancer	0.00011	0.000174	CcSEcCtD
Foscarnet—Cough—Epirubicin—breast cancer	0.000109	0.000173	CcSEcCtD
Foscarnet—Asthenia—Docetaxel—breast cancer	0.000108	0.000172	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GPX2—breast cancer	0.000108	0.00146	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA2—breast cancer	0.000108	0.00146	CbGpPWpGaD
Foscarnet—Convulsion—Epirubicin—breast cancer	0.000108	0.000172	CcSEcCtD
Foscarnet—Infection—Methotrexate—breast cancer	0.000108	0.000172	CcSEcCtD
Foscarnet—Hypertension—Epirubicin—breast cancer	0.000108	0.000171	CcSEcCtD
Foscarnet—Ill-defined disorder—Doxorubicin—breast cancer	0.000107	0.00017	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—MMP1—breast cancer	0.000107	0.00144	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—SULT1A1—breast cancer	0.000107	0.00144	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPX4—breast cancer	0.000107	0.00144	CbGpPWpGaD
Foscarnet—Pruritus—Docetaxel—breast cancer	0.000107	0.00017	CcSEcCtD
Foscarnet—Anaemia—Doxorubicin—breast cancer	0.000107	0.000169	CcSEcCtD
Foscarnet—Thrombocytopenia—Methotrexate—breast cancer	0.000107	0.000169	CcSEcCtD
Foscarnet—Myalgia—Epirubicin—breast cancer	0.000106	0.000169	CcSEcCtD
Foscarnet—Chest pain—Epirubicin—breast cancer	0.000106	0.000169	CcSEcCtD
Foscarnet—Arthralgia—Epirubicin—breast cancer	0.000106	0.000169	CcSEcCtD
Foscarnet—Agitation—Doxorubicin—breast cancer	0.000106	0.000169	CcSEcCtD
Foscarnet—Anxiety—Epirubicin—breast cancer	0.000106	0.000168	CcSEcCtD
Foscarnet—Nausea—Paclitaxel—breast cancer	0.000106	0.000168	CcSEcCtD
Foscarnet—Hyperhidrosis—Methotrexate—breast cancer	0.000105	0.000167	CcSEcCtD
Foscarnet—Discomfort—Epirubicin—breast cancer	0.000105	0.000167	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PLAU—breast cancer	0.000105	0.00142	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—CDK2—breast cancer	0.000105	0.00142	CbGpPWpGaD
Foscarnet—Asthenia—Capecitabine—breast cancer	0.000105	0.000167	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—IDH1—breast cancer	0.000104	0.00141	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTA1—breast cancer	0.000104	0.00141	CbGpPWpGaD
Foscarnet—Malaise—Doxorubicin—breast cancer	0.000104	0.000165	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—TFRC—breast cancer	0.000104	0.0014	CbGpPWpGaD
Foscarnet—Dry mouth—Epirubicin—breast cancer	0.000104	0.000165	CcSEcCtD
Foscarnet—Anorexia—Methotrexate—breast cancer	0.000104	0.000165	CcSEcCtD
Foscarnet—Pruritus—Capecitabine—breast cancer	0.000104	0.000164	CcSEcCtD
Foscarnet—Leukopenia—Doxorubicin—breast cancer	0.000103	0.000164	CcSEcCtD
Foscarnet—Diarrhoea—Docetaxel—breast cancer	0.000103	0.000164	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—NAT2—breast cancer	0.000103	0.00139	CbGpPWpGaD
Foscarnet—Confusional state—Epirubicin—breast cancer	0.000103	0.000163	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—CAV1—breast cancer	0.000103	0.00139	CbGpPWpGaD
Foscarnet—Palpitations—Doxorubicin—breast cancer	0.000102	0.000162	CcSEcCtD
Foscarnet—Oedema—Epirubicin—breast cancer	0.000102	0.000162	CcSEcCtD
Foscarnet—Hypotension—Methotrexate—breast cancer	0.000102	0.000161	CcSEcCtD
Foscarnet—Infection—Epirubicin—breast cancer	0.000101	0.000161	CcSEcCtD
Foscarnet—Cough—Doxorubicin—breast cancer	0.000101	0.00016	CcSEcCtD
Foscarnet—Convulsion—Doxorubicin—breast cancer	0.0001	0.000159	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—NCOA2—breast cancer	0.0001	0.00135	CbGpPWpGaD
Foscarnet—Diarrhoea—Capecitabine—breast cancer	0.0001	0.000159	CcSEcCtD
Foscarnet—Dizziness—Docetaxel—breast cancer	0.0001	0.000159	CcSEcCtD
Foscarnet—Thrombocytopenia—Epirubicin—breast cancer	9.98e-05	0.000158	CcSEcCtD
Foscarnet—Hypertension—Doxorubicin—breast cancer	9.98e-05	0.000158	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Methotrexate—breast cancer	9.93e-05	0.000157	CcSEcCtD
Foscarnet—Hyperhidrosis—Epirubicin—breast cancer	9.86e-05	0.000156	CcSEcCtD
Foscarnet—Insomnia—Methotrexate—breast cancer	9.85e-05	0.000156	CcSEcCtD
Foscarnet—Myalgia—Doxorubicin—breast cancer	9.84e-05	0.000156	CcSEcCtD
Foscarnet—Chest pain—Doxorubicin—breast cancer	9.84e-05	0.000156	CcSEcCtD
Foscarnet—Arthralgia—Doxorubicin—breast cancer	9.84e-05	0.000156	CcSEcCtD
Foscarnet—Anxiety—Doxorubicin—breast cancer	9.81e-05	0.000156	CcSEcCtD
Foscarnet—Paraesthesia—Methotrexate—breast cancer	9.78e-05	0.000155	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—FN1—breast cancer	9.77e-05	0.00132	CbGpPWpGaD
Foscarnet—Discomfort—Doxorubicin—breast cancer	9.72e-05	0.000154	CcSEcCtD
Foscarnet—Anorexia—Epirubicin—breast cancer	9.72e-05	0.000154	CcSEcCtD
Foscarnet—Dyspnoea—Methotrexate—breast cancer	9.71e-05	0.000154	CcSEcCtD
Foscarnet—Somnolence—Methotrexate—breast cancer	9.69e-05	0.000154	CcSEcCtD
Foscarnet—Dizziness—Capecitabine—breast cancer	9.68e-05	0.000154	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—NOS2—breast cancer	9.65e-05	0.0013	CbGpPWpGaD
Foscarnet—Dry mouth—Doxorubicin—breast cancer	9.62e-05	0.000153	CcSEcCtD
Foscarnet—Vomiting—Docetaxel—breast cancer	9.61e-05	0.000152	CcSEcCtD
Foscarnet—Dyspepsia—Methotrexate—breast cancer	9.59e-05	0.000152	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC5A5—breast cancer	9.55e-05	0.00129	CbGpPWpGaD
Foscarnet—Rash—Docetaxel—breast cancer	9.53e-05	0.000151	CcSEcCtD
Foscarnet—Hypotension—Epirubicin—breast cancer	9.53e-05	0.000151	CcSEcCtD
Foscarnet—Dermatitis—Docetaxel—breast cancer	9.52e-05	0.000151	CcSEcCtD
Foscarnet—Confusional state—Doxorubicin—breast cancer	9.51e-05	0.000151	CcSEcCtD
Foscarnet—Decreased appetite—Methotrexate—breast cancer	9.47e-05	0.00015	CcSEcCtD
Foscarnet—Headache—Docetaxel—breast cancer	9.47e-05	0.00015	CcSEcCtD
Foscarnet—Oedema—Doxorubicin—breast cancer	9.43e-05	0.00015	CcSEcCtD
Foscarnet—Fatigue—Methotrexate—breast cancer	9.39e-05	0.000149	CcSEcCtD
Foscarnet—Infection—Doxorubicin—breast cancer	9.37e-05	0.000149	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PIK3CG—breast cancer	9.35e-05	0.00126	CbGpPWpGaD
Foscarnet—Pain—Methotrexate—breast cancer	9.32e-05	0.000148	CcSEcCtD
Foscarnet—Vomiting—Capecitabine—breast cancer	9.31e-05	0.000148	CcSEcCtD
Foscarnet—Musculoskeletal discomfort—Epirubicin—breast cancer	9.29e-05	0.000147	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—EGF—breast cancer	9.24e-05	0.00125	CbGpPWpGaD
Foscarnet—Thrombocytopenia—Doxorubicin—breast cancer	9.24e-05	0.000147	CcSEcCtD
Foscarnet—Rash—Capecitabine—breast cancer	9.23e-05	0.000146	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—SLC2A1—breast cancer	9.23e-05	0.00125	CbGpPWpGaD
Foscarnet—Insomnia—Epirubicin—breast cancer	9.22e-05	0.000146	CcSEcCtD
Foscarnet—Dermatitis—Capecitabine—breast cancer	9.22e-05	0.000146	CcSEcCtD
Foscarnet—Headache—Capecitabine—breast cancer	9.17e-05	0.000145	CcSEcCtD
Foscarnet—Paraesthesia—Epirubicin—breast cancer	9.16e-05	0.000145	CcSEcCtD
Foscarnet—Hyperhidrosis—Doxorubicin—breast cancer	9.12e-05	0.000145	CcSEcCtD
Foscarnet—Dyspnoea—Epirubicin—breast cancer	9.09e-05	0.000144	CcSEcCtD
Foscarnet—Somnolence—Epirubicin—breast cancer	9.06e-05	0.000144	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—DPYD—breast cancer	9.06e-05	0.00122	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MED12—breast cancer	9.06e-05	0.00122	CbGpPWpGaD
Foscarnet—Anorexia—Doxorubicin—breast cancer	8.99e-05	0.000143	CcSEcCtD
Foscarnet—Nausea—Docetaxel—breast cancer	8.98e-05	0.000142	CcSEcCtD
Foscarnet—Feeling abnormal—Methotrexate—breast cancer	8.98e-05	0.000142	CcSEcCtD
Foscarnet—Dyspepsia—Epirubicin—breast cancer	8.97e-05	0.000142	CcSEcCtD
Foscarnet—SLC22A6—SLC-mediated transmembrane transport—ALB—breast cancer	8.97e-05	0.00121	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALDOA—breast cancer	8.92e-05	0.0012	CbGpPWpGaD
Foscarnet—Gastrointestinal pain—Methotrexate—breast cancer	8.91e-05	0.000141	CcSEcCtD
Foscarnet—Decreased appetite—Epirubicin—breast cancer	8.86e-05	0.000141	CcSEcCtD
Foscarnet—Hypotension—Doxorubicin—breast cancer	8.82e-05	0.00014	CcSEcCtD
Foscarnet—Fatigue—Epirubicin—breast cancer	8.79e-05	0.000139	CcSEcCtD
Foscarnet—Constipation—Epirubicin—breast cancer	8.72e-05	0.000138	CcSEcCtD
Foscarnet—Pain—Epirubicin—breast cancer	8.72e-05	0.000138	CcSEcCtD
Foscarnet—Nausea—Capecitabine—breast cancer	8.69e-05	0.000138	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—NCOA3—breast cancer	8.66e-05	0.00117	CbGpPWpGaD
Foscarnet—Abdominal pain—Methotrexate—breast cancer	8.61e-05	0.000137	CcSEcCtD
Foscarnet—Body temperature increased—Methotrexate—breast cancer	8.61e-05	0.000137	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC2A2—breast cancer	8.6e-05	0.00116	CbGpPWpGaD
Foscarnet—Musculoskeletal discomfort—Doxorubicin—breast cancer	8.59e-05	0.000136	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—IGF1—breast cancer	8.56e-05	0.00116	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT2—breast cancer	8.55e-05	0.00115	CbGpPWpGaD
Foscarnet—Insomnia—Doxorubicin—breast cancer	8.53e-05	0.000135	CcSEcCtD
Foscarnet—Paraesthesia—Doxorubicin—breast cancer	8.47e-05	0.000134	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—NCOA1—breast cancer	8.44e-05	0.00114	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCG2—breast cancer	8.42e-05	0.00114	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTR—breast cancer	8.42e-05	0.00114	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CPT1A—breast cancer	8.42e-05	0.00114	CbGpPWpGaD
Foscarnet—Dyspnoea—Doxorubicin—breast cancer	8.41e-05	0.000133	CcSEcCtD
Foscarnet—Feeling abnormal—Epirubicin—breast cancer	8.4e-05	0.000133	CcSEcCtD
Foscarnet—Somnolence—Doxorubicin—breast cancer	8.39e-05	0.000133	CcSEcCtD
Foscarnet—Gastrointestinal pain—Epirubicin—breast cancer	8.34e-05	0.000132	CcSEcCtD
Foscarnet—Dyspepsia—Doxorubicin—breast cancer	8.3e-05	0.000132	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—HPGDS—breast cancer	8.26e-05	0.00112	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—PLG—breast cancer	8.22e-05	0.00111	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CD—breast cancer	8.22e-05	0.00111	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HBA1—breast cancer	8.21e-05	0.00111	CbGpPWpGaD
Foscarnet—Decreased appetite—Doxorubicin—breast cancer	8.2e-05	0.00013	CcSEcCtD
Foscarnet—Fatigue—Doxorubicin—breast cancer	8.13e-05	0.000129	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—SERPINE1—breast cancer	8.13e-05	0.0011	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—ALB—breast cancer	8.11e-05	0.0011	CbGpPWpGaD
Foscarnet—Constipation—Doxorubicin—breast cancer	8.07e-05	0.000128	CcSEcCtD
Foscarnet—Pain—Doxorubicin—breast cancer	8.07e-05	0.000128	CcSEcCtD
Foscarnet—Abdominal pain—Epirubicin—breast cancer	8.06e-05	0.000128	CcSEcCtD
Foscarnet—Body temperature increased—Epirubicin—breast cancer	8.06e-05	0.000128	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—GSTT1—breast cancer	8.01e-05	0.00108	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ACHE—breast cancer	8.01e-05	0.00108	CbGpPWpGaD
Foscarnet—Asthenia—Methotrexate—breast cancer	7.82e-05	0.000124	CcSEcCtD
Foscarnet—Feeling abnormal—Doxorubicin—breast cancer	7.77e-05	0.000123	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—NOS3—breast cancer	7.76e-05	0.00105	CbGpPWpGaD
Foscarnet—Gastrointestinal pain—Doxorubicin—breast cancer	7.71e-05	0.000122	CcSEcCtD
Foscarnet—Pruritus—Methotrexate—breast cancer	7.71e-05	0.000122	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—HMOX1—breast cancer	7.59e-05	0.00102	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP17A1—breast cancer	7.58e-05	0.00102	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS1—breast cancer	7.51e-05	0.00101	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ENO1—breast cancer	7.51e-05	0.00101	CbGpPWpGaD
Foscarnet—Abdominal pain—Doxorubicin—breast cancer	7.46e-05	0.000118	CcSEcCtD
Foscarnet—Body temperature increased—Doxorubicin—breast cancer	7.46e-05	0.000118	CcSEcCtD
Foscarnet—Diarrhoea—Methotrexate—breast cancer	7.45e-05	0.000118	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP2D6—breast cancer	7.36e-05	0.000994	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—RAF1—breast cancer	7.34e-05	0.00099	CbGpPWpGaD
Foscarnet—Asthenia—Epirubicin—breast cancer	7.32e-05	0.000116	CcSEcCtD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ABCB1—breast cancer	7.28e-05	0.000983	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOA2—breast cancer	7.23e-05	0.000976	CbGpPWpGaD
Foscarnet—Pruritus—Epirubicin—breast cancer	7.21e-05	0.000114	CcSEcCtD
Foscarnet—Dizziness—Methotrexate—breast cancer	7.2e-05	0.000114	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—PIK3CB—breast cancer	7.16e-05	0.000967	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—ALB—breast cancer	7.02e-05	0.000948	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—FASN—breast cancer	7.01e-05	0.000946	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—BCHE—breast cancer	6.98e-05	0.000942	CbGpPWpGaD
Foscarnet—Diarrhoea—Epirubicin—breast cancer	6.98e-05	0.000111	CcSEcCtD
Foscarnet—Vomiting—Methotrexate—breast cancer	6.93e-05	0.00011	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC5A5—breast cancer	6.89e-05	0.000931	CbGpPWpGaD
Foscarnet—Rash—Methotrexate—breast cancer	6.87e-05	0.000109	CcSEcCtD
Foscarnet—Dermatitis—Methotrexate—breast cancer	6.86e-05	0.000109	CcSEcCtD
Foscarnet—Headache—Methotrexate—breast cancer	6.83e-05	0.000108	CcSEcCtD
Foscarnet—Asthenia—Doxorubicin—breast cancer	6.77e-05	0.000107	CcSEcCtD
Foscarnet—Dizziness—Epirubicin—breast cancer	6.74e-05	0.000107	CcSEcCtD
Foscarnet—Pruritus—Doxorubicin—breast cancer	6.67e-05	0.000106	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—SLC2A1—breast cancer	6.66e-05	0.000899	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NQO1—breast cancer	6.66e-05	0.000899	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—IL2—breast cancer	6.58e-05	0.000888	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP3A4—breast cancer	6.49e-05	0.000877	CbGpPWpGaD
Foscarnet—Vomiting—Epirubicin—breast cancer	6.48e-05	0.000103	CcSEcCtD
Foscarnet—Nausea—Methotrexate—breast cancer	6.47e-05	0.000103	CcSEcCtD
Foscarnet—Diarrhoea—Doxorubicin—breast cancer	6.45e-05	0.000102	CcSEcCtD
Foscarnet—Rash—Epirubicin—breast cancer	6.43e-05	0.000102	CcSEcCtD
Foscarnet—Dermatitis—Epirubicin—breast cancer	6.42e-05	0.000102	CcSEcCtD
Foscarnet—Headache—Epirubicin—breast cancer	6.39e-05	0.000101	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP1B1—breast cancer	6.38e-05	0.000862	CbGpPWpGaD
Foscarnet—SLC16A1—Transmembrane transport of small molecules—RAF1—breast cancer	6.35e-05	0.000857	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HSP90AA1—breast cancer	6.26e-05	0.000845	CbGpPWpGaD
Foscarnet—Dizziness—Doxorubicin—breast cancer	6.24e-05	9.9e-05	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—NCOA1—breast cancer	6.09e-05	0.000822	CbGpPWpGaD
Foscarnet—Nausea—Epirubicin—breast cancer	6.06e-05	9.61e-05	CcSEcCtD
Foscarnet—SLC16A1—Metabolism—CYP19A1—breast cancer	6e-05	0.00081	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—STK11—breast cancer	6e-05	0.00081	CbGpPWpGaD
Foscarnet—Vomiting—Doxorubicin—breast cancer	6e-05	9.51e-05	CcSEcCtD
Foscarnet—Rash—Doxorubicin—breast cancer	5.95e-05	9.44e-05	CcSEcCtD
Foscarnet—Dermatitis—Doxorubicin—breast cancer	5.94e-05	9.43e-05	CcSEcCtD
Foscarnet—Headache—Doxorubicin—breast cancer	5.91e-05	9.37e-05	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—SRC—breast cancer	5.74e-05	0.000775	CbGpPWpGaD
Foscarnet—Nausea—Doxorubicin—breast cancer	5.6e-05	8.89e-05	CcSEcCtD
Foscarnet—SLC16A1—Hemostasis—VEGFA—breast cancer	5.59e-05	0.000755	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—COMT—breast cancer	5.58e-05	0.000753	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTP1—breast cancer	5.55e-05	0.00075	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—HMOX1—breast cancer	5.48e-05	0.000739	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ITPR1—breast cancer	5.46e-05	0.000738	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—MAPK3—breast cancer	5.29e-05	0.000714	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ABCB1—breast cancer	5.26e-05	0.00071	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—TYMS—breast cancer	5.16e-05	0.000697	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TGFB1—breast cancer	5.13e-05	0.000693	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PLA2G4A—breast cancer	5.1e-05	0.000689	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GSTM1—breast cancer	5.1e-05	0.000689	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NCOR1—breast cancer	5.1e-05	0.000689	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—GPX1—breast cancer	4.89e-05	0.00066	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CYP1A1—breast cancer	4.84e-05	0.000653	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ERCC2—breast cancer	4.8e-05	0.000648	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—KRAS—breast cancer	4.75e-05	0.000642	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—ALB—breast cancer	4.56e-05	0.000615	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—MTHFR—breast cancer	4.51e-05	0.000609	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—PIK3CA—breast cancer	4.37e-05	0.000589	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—TP53—breast cancer	4.22e-05	0.00057	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—CAV1—breast cancer	4.16e-05	0.000562	CbGpPWpGaD
Foscarnet—SLC22A6—Transmembrane transport of small molecules—RAF1—breast cancer	4.12e-05	0.000556	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—HRAS—breast cancer	4.04e-05	0.000545	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CG—breast cancer	3.79e-05	0.000512	CbGpPWpGaD
Foscarnet—SLC16A1—Hemostasis—AKT1—breast cancer	3.57e-05	0.000481	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CD—breast cancer	3.33e-05	0.00045	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—ALB—breast cancer	3.29e-05	0.000444	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—NOS3—breast cancer	3.15e-05	0.000425	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CB—breast cancer	2.9e-05	0.000392	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTGS2—breast cancer	2.88e-05	0.000388	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PTEN—breast cancer	2.51e-05	0.000339	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—PIK3CA—breast cancer	1.77e-05	0.000239	CbGpPWpGaD
Foscarnet—SLC16A1—Metabolism—AKT1—breast cancer	1.45e-05	0.000195	CbGpPWpGaD
